Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Talbot

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Infection Control and Hospital Epidemiology|June 1, 1990
Risk factors for Clostridium difficile toxin-associated diarrheaE Brown, G H Talbot, P Axelrod, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2001
Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitisG H Talbot, D W Kennedy, W M Scheld, et al.
Clinical Therapeutics|January 23, 1999
Effect of Maalox on the oral absorption of sparfloxacinR D Johnson, M B Dorr, G H Talbot, et al.
The American Journal of Medicine|December 1, 1989
Risk factors for nosocomial candidemia: a case-control study in adults without leukemiaJ Bross, G H Talbot, G Maislin, et al.
Clinical Therapeutics|August 10, 1999
Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycinB A Lipsky, J Unowsky, H Zhang, et al.
Clinical Therapeutics|October 6, 1999
The effect of terfenadine on the cardiac pharmacodynamics of sparfloxacinJ Morganroth, T Hunt, M B Dorr, et al.
Clinical Therapeutics|July 9, 1999
Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infectionsM Dowzicky, H Nadler, M B Dorr, et al.
Clinical Therapeutics|August 27, 1999
The cardiac pharmacodynamics of therapeutic doses of sparfloxacinJ Morganroth, T Hunt, M B Dorr, et al.
Clinical Therapeutics|March 25, 1999
Safety profile of sparfloxacin, a new fluoroquinolone antibioticB A Lipsky, M B Dorr, D J Magner, et al.
The Pediatric Infectious Disease Journal|April 1, 1988
Vertical transmission of Citrobacter diversus from mother to infantA Finn, G H Talbot, E Anday, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Infection Control and Hospital Epidemiology|June 1, 1990
Risk factors for Clostridium difficile toxin-associated diarrheaE Brown, G H Talbot, P Axelrod, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2001
Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitisG H Talbot, D W Kennedy, W M Scheld, et al.
Clinical Therapeutics|January 23, 1999
Effect of Maalox on the oral absorption of sparfloxacinR D Johnson, M B Dorr, G H Talbot, et al.
The American Journal of Medicine|December 1, 1989
Risk factors for nosocomial candidemia: a case-control study in adults without leukemiaJ Bross, G H Talbot, G Maislin, et al.
Clinical Therapeutics|August 10, 1999
Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycinB A Lipsky, J Unowsky, H Zhang, et al.
Clinical Therapeutics|October 6, 1999
The effect of terfenadine on the cardiac pharmacodynamics of sparfloxacinJ Morganroth, T Hunt, M B Dorr, et al.
Clinical Therapeutics|July 9, 1999
Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infectionsM Dowzicky, H Nadler, M B Dorr, et al.
Clinical Therapeutics|August 27, 1999
The cardiac pharmacodynamics of therapeutic doses of sparfloxacinJ Morganroth, T Hunt, M B Dorr, et al.
Clinical Therapeutics|March 25, 1999
Safety profile of sparfloxacin, a new fluoroquinolone antibioticB A Lipsky, M B Dorr, D J Magner, et al.
The Pediatric Infectious Disease Journal|April 1, 1988
Vertical transmission of Citrobacter diversus from mother to infantA Finn, G H Talbot, E Anday, et al.
Pageof 8